Aytu Biopharma, Inc. (AYTU)
2.29
+0.05
(+2.23%)
USD |
NASDAQ |
May 29, 16:00
2.25
-0.04
(-1.75%)
After-Hours: 20:00
Aytu Biopharma EPS Diluted (Quarterly) : -0.5345 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Talphera, Inc. | -0.0366 |
| Aquestive Therapeutics, Inc. | -0.0657 |
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.618M |
| Revenue (Quarterly) | 12.41M |
| Total Expenses (Quarterly) | 18.03M |
| Enterprise Value | 20.80M |
| Gross Profit Margin (Quarterly) | 55.10% |
| Profit Margin (Quarterly) | -45.27% |
| Earnings Yield | -200.2% |
| Normalized Earnings Yield | -163.00 |